IGM Biosciences, Inc. (NASDAQ:IGMS – Get Rating)’s share price traded down 6.5% during mid-day trading on Tuesday after Guggenheim lowered their price target on the stock from $40.00 to $38.00. The company traded as low as $12.84 and last traded at $12.89. 52,848 shares were traded during mid-day trading, a decline of 76% from the […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) – Analysts at Capital One Financial decreased their FY2027 earnings estimates for IDEAYA Biosciences in a research note issued on Wednesday, May 10th. Capital One Financial analyst Z. Jallah now anticipates that the company will post earnings per share of $0.29 for the year, down from their prior […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.49) EPS for the quarter, topping the consensus estimate of ($0.52) by $0.03, Briefing.com reports. The company had revenue of $7.90 million during the quarter, compared to analyst estimates of $5.38 million. IDEAYA Biosciences had a negative return on […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) – Oppenheimer increased their FY2025 earnings estimates for shares of IDEAYA Biosciences in a report released on Monday, April 24th. Oppenheimer analyst M. Biegler now expects that the company will post earnings of ($2.42) per share for the year, up from their previous estimate of ($2.50). The consensus […]
Stifel Nicolaus upgraded shares of IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) from a hold rating to a buy rating in a research note published on Monday, The Fly reports. The brokerage currently has $24.00 price objective on the stock, up from their prior price objective of $18.00. Other equities research analysts also recently issued research […]